

Indus Biotech Profile
Key Indicators
- Authorised Capital ₹ 43.00 Cr
- Paid Up Capital ₹ 15.77 Cr
- Company Age 30 Year, 16 Days
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 12.97 Cr
- Satisfied Charges ₹ 22.02 Cr
- Revenue Growth 4.82%
- Profit Growth 128.44%
- Ebitda -2.81%
- Net Worth 268.82%
- Total Assets -24.32%
About Indus Biotech
Indus Biotech Limited (IBL) is a leading Public Limited Indian Non-Government Company incorporated in India on 16 February 1995 and has a history of 30 years. Its registered office is in Pune, Maharashtra, India.
The Corporate was formerly known as Indus Biotech Private Limited. The Company is engaged in the Life Sciences Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 43.00 Cr and a paid-up capital of Rs 15.77 Cr.
The company currently has active open charges totaling ₹12.97 Cr. The company has closed loans amounting to ₹22.02 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Indus Biotech Limited India are Achyut Huilgol as CFO and Rucha Khaire as Company Secretary. Anil Kumar, Rajan Srinivasan, Ranjeet Srinivasan, and Three other members serve as directors at the Company.
Company Details
- Location
Pune, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U24231MH1995PLC085656
- Company No.
085656
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
16 Feb 1995
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Pune
Industry
Who are the key members and board of directors at Indus Biotech?
Executive Team (3)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Achyut Huilgol ![]() | CFO | 14-Mar-2018 | Current |
Sunil Bhaskaran ![]() | Managing Director | 16-Feb-1995 | Current |
Rucha Khaire ![]() | Company Secretary | 19-Jun-2017 | Current |
Board Members (5)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Himanshu Nivsarkar ![]() | Nominee Director | 24-Mar-2017 | Current |
Anil Kumar ![]() | Director | 15-Nov-2021 | Current |
Rajan Srinivasan ![]() | Director | 01-Jan-2001 | Current |
Ranjeet Srinivasan ![]() | Director | 16-Feb-1995 | Current |
Shrikant Patil ![]() | Director | 15-Nov-2021 | Current |
Financial Performance of Indus Biotech.
Indus Biotech Limited, for the financial year ended 2022, experienced modest growth in revenue, with a 4.82% increase. The company also saw a substantial improvement in profitability, with a 128.44% increase in profit. The company's net worth Soared by an impressive increase of 268.82%.


- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Indus Biotech?
In 2022, Indus Biotech had a promoter holding of 39.67% and a public holding of 60.33%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Related Corporates (Common Directorship)
- Argon Company Connectivity Services Private Limited
Rajan Srinivasan is a mutual person
- Trigonella Labs Private Limited
Himanshu Nivsarkar is a mutual person
- C.T.R. Manufacturing Industries Private Limited
Anil Kumar is a mutual person
- Mithi Software Technologies Private Liimited
Shrikant Patil is a mutual person
- Town Essentials Private Limited
Shrikant Patil is a mutual person
- 100Watts.Tech Private Limited
Shrikant Patil is a mutual person
Charges (Loans)
₹12.97 Cr
₹22.02 Cr
Charges Breakdown by Lending Institutions
- Others : 12.04 Cr
- Vijaya Bank : 0.93 Cr
Latest Charge Details
Date | Lender | Amount | Status |
---|---|---|---|
23 Jun 2021 | Others | ₹12.04 Cr | Open |
15 Jun 2017 | Vijaya Bank | ₹9.27 M | Open |
27 Oct 2015 | Others | ₹13.48 Cr | Satisfied |
15 Oct 2011 | Vijaya Bank | ₹5.20 M | Satisfied |
25 Aug 2009 | Vijaya Bank | ₹4.00 Cr | Satisfied |
How Many Employees Work at Indus Biotech?
Indus Biotech has a workforce of 138 employees as of Mar 30, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Indus Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Indus Biotech's trajectory.
Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Latest Updates, News, and FAQs on Indus Biotech
Recent activity within the organization
- Annual General Meeting
Indus Biotech Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
- Balance Sheet
Indus Biotech Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Pune.
- Charges
A charge with Others of Rs. 12.04 Cr registered on 23 Jun 2021 with Charge ID 100459522 was modified on 14 Mar 2023.
- Director Appointment
Anil Pratap Kumar was appointed as a Director was appointed as a Director on 15 Nov 2021 & has been associated with this company since 3 years 3 months .
- Director Appointment
Shrikant Jayawant Patil was appointed as a Director was appointed as a Director on 15 Nov 2021 & has been associated with this company since 3 years 3 months .
- Charges
A charge with Others amounted to Rs. 12.04 Cr with Charge ID 100459522 was registered on 23 Jun 2021.
Recent News, Updates & Announcement
- Kotak PE to Sell Stake in Indus Biotech's IPO, Targets Valuation of ₹2,000 Crore.
Kotak PE invested in Indus Biotech 11 years ago and is now planning to sell its stake in the company's upcoming IPO. The firm is targeting a valuation of around ₹2,000 crore and has hired ICICI Securities and IIFL as advisers. Indus Biotech manufactures dietary ingredients and has been granted 169 patents. Kotak PE has been an active investor in pharmaceutical, healthcare, and wellness segments..
Frequently asked questions
What is the Incorporation or founding date of Indus Biotech Limited?
Indus Biotech Limited was incorporated on 16 Feb 1995.
What is authorized share capital and paid-up capital of Indus Biotech Limited?
The authorized share capital of Indus Biotech Limited is ₹ 43.00 Cr and paid-up capital is ₹ 15.77 Cr.
Who are the current board members & directors of Indus Biotech Limited?
Currently 8 directors are associated with Indus Biotech Limited.
- Anil Pratap Kumar
- Rajan Ramaswamy Srinivasan
- Ranjeet Palliyil Srinivasan
- Sunil Dutt Bhaskaran
- Shrikant Jayawant Patil
- Himanshu Nivsarkar
- Achyut Jayatirthrao Huilgol
- Rucha Shamkant Khaire
What is the registered address of Indus Biotech Limited?
As per Ministry of Corporate Affairs (Mca), the registered address of Indus Biotech Limited is 1 Rahul Residency Plot Nos. 6 7 Off Salunke Vihar Road, Kondhwa India, Pune, Maharashtra, 411048.
What is the corporate identification number (CIN) and company number of Indus Biotech Limited?
The corporate identification number (CIN) of Indus Biotech Limited is U24231MH1995PLC085656 and the company number is 085656 as per Ministry of Corporate Affairs (MCA).
What is the official website of Indus Biotech Limited?
The Official website of Indus Biotech Limited is https://www.indusbiotech.com
What has been the recent revenue trend for Indus Biotech Limited?
According to the financial reports for the fiscal year 2022, the revenue trend for Indus Biotech Limited has risen by 4.82%.
How many employees does Indus Biotech Limited currently have?
As Per 2022 financial reports, 138 employees are currently employed by Indus Biotech Limited.
What change has been observed in the net worth of Indus Biotech Limited, and by what percentage?
The financial reports for the fiscal year 2022 indicates that The net worth of Indus Biotech Limited has experienced an upsurge of 268.82%.
What are the total open charges for Indus Biotech Limited?
As per the financial statements for fiscal Year 2022, The total open charges for Indus Biotech Limited amount to ₹ 12.97 Cr.
When was the last Balance Sheet of Indus Biotech Limited filed with the ROC?
The most recent Balance Sheet for Indus Biotech Limited was filed with the ROC on 31 Mar 2024.
People also Viewed
- Nitin DeshmukhDirector
AN
Anil NanavatiDirectorRS
Rajeshree SabnavisDirectorJM
Jaiprakash MudakkanaveetilDirector
Similar Companies Based on Biotechnology
- Venkateshwara B.V. Biocorp Private Limited Pune, Maharashtra, India
- Sanofi Healthcare India Private Limited Mumbai, Maharashtra, India
- Biotechnology Industry Research Assistance Council Delhi, India
- Invitrogen Bioservices India Private Limited Bangaluru, Karnataka, India
- Ecso Global Private Limited New Delhi, India
- Gennova Biopharmaceuticals Limited Pune, Maharashtra, India
- Aurigene Oncology Limited Bangaluru, Karnataka, India